Stocks and Investing Stocks and Investing
Mon, July 23, 2012

Matthew Harrison Maintained (BMRN) at Strong Buy with Increased Target to $52 on, Jul 23rd, 2012


Published on 2024-10-25 00:04:12 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Increased Target from $43 to $52 on, Jul 23rd, 2012.

Matthew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Martin Auster of "UBS" Initiated at Strong Buy and Held Target at $43 on, Thursday, April 12th, 2012
  • Michelle Gilson of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $43 on, Monday, March 26th, 2012
Contributing Sources